Ortega M V, Kim Y, Hung K, James K, Savitt L, Von Bargen E, Bordeianou L G, Weinstein M M
Division of Female Pelvic Medicine and Reconstructive Surgery, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA, USA.
Tech Coloproctol. 2022 Jan;26(1):29-34. doi: 10.1007/s10151-021-02518-4. Epub 2021 Nov 24.
The aim of our study was to characterize urogenital symptoms in women with and without constipation, and by severity of constipation.
This was a retrospective cohort study conducted at a pelvic floor disorder center in a tertiary healthcare facility from May 2007 through August 2019 and completed an intake questionnaire were included. We collected demographic, physical exam data and quality of life outcomes. The Urinary Distress Inventory (UDI-6) was used to assess urogenital symptoms. Women with constipation completed the Constipation Severity Instrument (CSI). We excluded women with a history of a bowel resection, inflammatory bowel disease, or pelvic organ prolapse symptoms. The cohort was then divided into two groups, constipated and non-constipated, and the prevalence and severity of urogenital-associated symptoms were compared. A secondary analysis was made among constipated subjects stratified by constipation severity based on CSI scores.
During the study period, 875 women (59.5%) had chronic constipation. Women with chronic constipation were more likely to experience urogenital symptoms, such as dyspareunia, urinary hesitancy, and a sensation of incomplete bladder emptying (all p < 0.05). Moreover, on univariate analysis, women with high CSI scores (75 percentile or higher) were found to have higher UDI-6 scores, increased bladder splinting, pad use, urinary frequency and dyspareunia while on multivariate analysis higher UDI score, increased bladder splinting, urinary frequency and dyspareunia were significantly associated (p < 0.05).
We found that the presence and severity of chronic constipation worsened the degree of bother from urogenital symptoms. Given that chronic constipation can modulate urogenital symptoms, our study suggests that pelvic floor specialists should assess the presence and severity of urogenital and bowel symptoms to provide comprehensive care.
我们研究的目的是描述有无便秘的女性的泌尿生殖系统症状,以及根据便秘的严重程度进行描述。
这是一项回顾性队列研究,于2007年5月至2019年8月在一家三级医疗机构的盆底功能障碍中心进行,纳入了完成入院调查问卷的患者。我们收集了人口统计学、体格检查数据和生活质量结果。使用泌尿困扰量表(UDI-6)评估泌尿生殖系统症状。便秘女性完成便秘严重程度量表(CSI)。我们排除了有肠道切除术、炎症性肠病或盆腔器官脱垂症状病史的女性。然后将队列分为便秘组和非便秘组,比较泌尿生殖系统相关症状的患病率和严重程度。根据CSI评分对便秘受试者进行分层,进行二次分析。
在研究期间,875名女性(59.5%)患有慢性便秘。慢性便秘女性更有可能出现泌尿生殖系统症状,如性交困难、排尿犹豫和膀胱排空不全感(所有p<0.05)。此外,单因素分析发现,CSI评分高(第75百分位数或更高)的女性UDI-6评分更高,膀胱夹闭、使用护垫、尿频和性交困难增加,而多因素分析发现,UDI评分更高、膀胱夹闭、尿频和性交困难增加显著相关(p<0.05)。
我们发现慢性便秘的存在和严重程度会加重泌尿生殖系统症状的困扰程度。鉴于慢性便秘可调节泌尿生殖系统症状,我们的研究表明,盆底专家应评估泌尿生殖系统和肠道症状的存在和严重程度,以提供全面的护理。